Article
Richter's syndrome: Novel and promising therapeutic alternatives.
Best practice & research. Clinical haematology - 1 Mar 2016
Rossi Davide
Abstract excerpt
Richter's syndrome (RS) is the development of an aggressive lymphoma in patients with a previous or concomitant diagnosis of chronic lymphocytic leukemia (CLL). The incidence rate for RS is ∼0.5% per year of observation. In the presence of clinical suspicious of RS, diagnosis of transformation and choice of the site of biopsy may take advantage of 18FDG PET/CT. Molecular lesions of tumor suppression regulators...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
